Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to ...

"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

But weight loss drugs require a prescription, tend to be expensive, and aren't usually covered by insurance if prescribed for weight loss only. People with low income may qualify to obtain the ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs, she had the briefest of ...

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

A significant concern is the prescription of Wegovy ... not been approved for NHS use solely as a weight-loss treatment, the rising demand for such drugs could lead to supply shortages.